Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical ...

Telemedicine is delivering hope to the homes of pancreatic cancer patients through a first-of-its-kind clinical trial.

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

DelveInsight's Pancreatic Cancer Market Insights report includes a comprehensive understanding of current treatment practices, ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...

Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...

“Cancer cells from patient’s primary tumours that ended up relapsing in the liver or the lung early on adopt cellular states ...

"Cancer cells from patient's primary tumours that ended up relapsing in the liver or the lung early on adopt cellular states ...

Tumor treating fields are emerging as a promising option for treating a range of cancer types. Here’s a look at the evidence ...

Pancreatic cancer remains the deadliest cancer due to late diagnosis and poor CT visibility, leaving just 10% alive at five years.